Definition of responder: introduction

被引:1
作者
Comi, Giancarlo [1 ,2 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Neurol, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Inst Expt Neurol, I-20132 Milan, Italy
关键词
induction therapy; escalating therapy; immunomodulary treatments; immunosuppressive treatments;
D O I
10.1007/s10072-008-0938-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Availability of multiple disase modifiyng treatments in multiple sclerosis requires the definition of criteria to classify the response to individual treatments, to open the possibility to substitute a drug with another potentially effective drugs in case of treatment failure or to add a second treatment if the first is classified as partially effective. Because of the large inter and intra- individual variability of the disease evolution such a classification is frequently difficult. Different clinical and magnetic resonance imaging (MRI) parameters have been proposed. Measures of disease activity, attacks and active MRI lesions, are ore suitable, particularly in the remitting phase of the disease.
引用
收藏
页码:S209 / S210
页数:2
相关论文
共 10 条
[1]
Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO
[2]
2-#
[3]
Early treatment [J].
Comi, G .
NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 1) :S8-S12
[4]
Clinically isolated syndrome: the rationale for early treatment [J].
Comi, Giancarlo .
NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (05) :234-235
[5]
Treatment optimization in multiple sclerosis [J].
Freedman, MS ;
Patry, DG ;
Grand'Maison, F ;
Myles, ML ;
Paty, DW ;
Selchen, DH .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (02) :157-168
[6]
Autologous haematopoietic stem-cell transplantation in multiple sclerosis [J].
Mancardi, Gianluigi ;
Saccardi, Riccardo .
LANCET NEUROLOGY, 2008, 7 (07) :626-636
[7]
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis [J].
Metz, Imke ;
Lucchinetti, Claudia F. ;
Openshaw, Harry ;
Garcia-Merino, Antonio ;
Lassmann, Hans ;
Freedman, Marc S. ;
Atkins, Harold L. ;
Azzarelli, Biagio ;
Kolar, Oldrich J. ;
Brueck, Wolfgang .
BRAIN, 2007, 130 :1254-1262
[8]
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients [J].
Río, J ;
Nos, C ;
Tintoré, M ;
Téllez, N ;
Galán, I ;
Pelayo, R ;
Comabella, M ;
Montalban, X .
ANNALS OF NEUROLOGY, 2006, 59 (02) :344-352
[9]
Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis [J].
Rudick, RA .
JOURNAL OF NEUROIMAGING, 2004, 14 (03) :54S-64S
[10]
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis [J].
Tomassini, V ;
Paolillo, A ;
Russo, P ;
Giugni, E ;
Prosperini, L ;
Gasperini, C ;
Antonelli, G ;
Bastianello, S ;
Pozzilli, C .
JOURNAL OF NEUROLOGY, 2006, 253 (03) :287-293